A Verdict for Glimepiride: Effective and Not Guilty of Cardiovascular Harm-Reference-Cited by-同舟云学术

A Verdict for Glimepiride: Effective and Not Guilty of Cardiovascular Harm

Published:2019-11-12 Issue:12 Volume:42 Page:2161-2163
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Riddle Matthew C.¹^ORCID

Affiliation:

1. Division of Endocrinology, Diabetes & Clinical Nutrition, Oregon Health & Science University, Portland, OR

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/42/12/2161/528855/dci190034.pdf

Reference19 articles.

1. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results;Meinert;Diabetes,1970

2. Modern sulfonylureas: dangerous or wrongly accused?;Riddle;Diabetes Care,2017

3. Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide;Klepzig;Eur Heart J,1999

4. Mortality risk among sulfonylureas: a systematic review and network meta-analysis;Simpson;Lancet Diabetes Endocrinol,2015

5. Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer;Abdelmoneim;Diabetes Obes Metab,2015

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nano-encapsulation and characterizations of glimepiride drug with chitosan nanoparticles and its in vitro drug release kinetics and antidiabetic activity;Materials Today Communications;2024-06

2. Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus;Scientific Reports;2023-04-18

3. Glimepiride use is associated with reduced cardiovascular mortality in patients with type 2 diabetes and chronic heart failure: a prospective cohort study;European Journal of Preventive Cardiology;2022-12-27

4. Pharmacotherapy of type 2 diabetes: An update and future directions;Metabolism;2022-12

5. The Enhanced Cardiac Outcome of Conjugated SGLT2 Inhibitors and GLP-1RA Therapy in Diabetic Patients;Current Cardiology Reports;2022-01